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Abstract
Most of the bacterial species that form part of the biosphere have never been cultivated. In this situation, a comprehensive study of
bacterial communities requires the utilization of non-culture-based methods, which have been named metagenomics. In this paper we
review the use of different metagenomic techniques for understanding the effect of antibiotics on microbial communities, to synthesize
new antimicrobial compounds and to analyse the distribution of antibiotic resistance genes in different ecosystems. These techniques
include functional metagenomics, which serves to ﬁnd new antibiotics or new antibiotic resistance genes, and descriptive metagenomics,
which serves to analyse changes in the composition of the microbiota and to track the presence and abundance of already known anti-
biotic resistance genes in different ecosystems.
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Introduction
Antibiotics are among the most successful therapeutic com-
pounds developed by humans. However, one issue that is
not so frequently taken into consideration is that antibiotics
are also pollutants that may produce important effects on
the structure of natural bacterial populations [1]. Most
studies on antibiotic resistance refer to the mechanisms of
emergence and dissemination of resistance determinants in
bacterial pathogens [2]. Nevertheless, antibiotics may alter
as well the overall microbial populations in natural ecosys-
tems, being particularly relevant for the microorganisms
(pathogens and commensals) that colonize ecosystems in
close contact with humans. These habitats are the ones
presenting the highest probabilities of suffering contamina-
tion by antibiotics together with gene transfer elements
containing antibiotic resistance determinants [3–5]. Learning
the impact that the release of antibiotics and resistance
determinants may have on natural microbial populations is
a relevant topic for a comprehensive understanding of the
population dynamics of antibiotic resistance [4]. For this
goal, the utilization of non-culture-based techniques
(metagenomics) is required for describing more accurately
the changes in bacterial populations confronted with antibi-
otic contamination.
Antibiotic resistance is a relevant health problem with
consequences, not just for the treatment of infections, but
also for the utilization of medical and surgical techniques
that, like cancer chemotherapy or transplantation, involve
immunosuppression of the patient. In the current situation,
with few new antibiotics in the discovery pipeline, functional
metagenomics can be useful for searching for new antimicro-
bials without the need for culturing the producer organisms.
In this short review, we summarize recent progress on the
utilization of metagenomics tools for tracking resistance ele-
ments, deciphering the effect of antibiotics on microbial com-
munities and searching for new antimicrobials useful for
treating infections by human pathogens.
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Functional metagenomics
Functional genomics is being used for searching for speciﬁc
activities without the need for culturing the organisms har-
bouring the pathways involved. This approach was used ear-
lier and two antibiotic compounds (turbomycin A and B),
with a wide spectrum of activity against Gram-positive and
Gram-negative bacteria, were described [6]. More recently, a
project based on the analysis of so-called disease-suppressive
soils [7] further demonstrated the feasibility of metagenomic
approaches for searching novel antimicrobials. This project
was based on the original idea from Waksman and Woodruff
[8] indicating that soils must have compounds capable of
inhibiting pathogens because these bacteria are rarely found
in natural, non-clinical ecosystems. Using this theoretical
approach, libraries were constructed using DNA from soils
in which pathogens were absent. Two types of screening
were performed, one by direct searching of clones capable
of inhibiting growth of target pathogens, and another looking
for polyketide synthases because polyketides constitute a rel-
evant family of drugs. By using both approaches, novel activi-
ties and novel synthases were found indicating that functional
metagenomic approaches constitute an appealing alternative
in the search for new antimicrobials [7].
Descriptive metagenomics
Metagenomics is currently being used for describing the
structure of microbial populations. Since most microorgan-
isms have not been cultured, metagenomics is a more com-
prehensive methodology than culture-based techniques. The
description of microbiota can be addressed by two comple-
mentary approaches: analysis of the distribution of microbial
species or analysis of the distribution of genes. Whereas the
ﬁrst approach serves for understanding broadly the popula-
tion dynamics of the microorganisms present in a given eco-
system, the second is useful for understanding the global
metabolism of the microbiota present in a given ecosystem.
The analysis of ribosomal RNA has been the method of
choice for describing the structure of microbiota. Originally,
the method was based on study of the most abundant spe-
cies using denaturing gradient gel electrophoresis and
sequencing. However, the availability of high-throughput
methodologies allows a more precise description of the spe-
cies present in a given environment. The most useful tech-
nologies for in-depth analysis of microbiota are based on the
use of 16S RNA microarrays [9,10] and straightforward anal-
ysis using recent massive sequencing methods. Massive
sequencing has served as well to study correlations between
the microbiota of people with different diets, diseases and
ages and for tracking what can be considered as the core
human metagenome [11,12]. Nevertheless, and although anti-
biotics can dramatically impact environmental and human
microbiota and there exist useful tools for tracking these
changes, the number of papers referenced in PubMed and
that can be found using the query [(metagenomic*) AND
(antibiotic* OR antimicrobial*)] is still very low, although
these types of studies are increasing (Fig. 1). Among the
papers on this topic, it has been described that the use of
antibiotics challenges gut microbiota and that these changes
correlate with changes in the host response as well [13],
thus highlighting that antibiotics are not only good therapeu-
tic drugs but that they can produce relevant secondary
effects in our microbiota, which are not just selection of
resistance. Indeed, treatment with sub-inhibitory concentra-
tions of antibiotics produces a relevant shift in the structure
of gut microbiota; however, it does not correlate with
enrichment in antibiotic resistance determinants [14]. It is
important to know whether antibiotic-induced changes in
the microbiota are stable or the system is recovered once
antibiotic treatment ceases. One recently published paper
suggests that human microbiota presents a large degree of
homeostasis, because it suffers dramatic changes in the pres-
ence of antibiotics but the system is recovered just 1 week
after antibiotic removal [15]. An important aspect, not taken
into consideration in these papers that analyse the overall
population structure based upon 16S RNA, is whether this
recovery also occurs at the ﬁne grain level. Studies on this
topic would address two issues: clonal expansion and gene
FIG. 1. Number of papers on antibiotics and metagenomics that can
be found on PubMed. The ﬁgure shows the distribution along time
of papers recorded in PubMed using the query [(metagenomic*)
AND (antibiotic* OR antimicrobial*)]. The search was made on
17 October 2011.
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enrichment. Clonal expansion refers to the increased preva-
lence of a given clone because it is better adapted than the
others to a speciﬁc habitat. Gene enrichment consists in the
increase in the abundance of a speciﬁc gene, which usually is
transferred between different members of the population.
These two processes can be linked if a given gene confers an
advantage to a speciﬁc clone, in which case clonal expansion
will be favoured. The opposite situation is also frequent; the
acquisition of a speciﬁc gene by a proﬁcient clone will allow
the enrichment of the former, since the use of antibiotics at
therapeutic concentrations will select the clones harbouring
resistance genes or resistance mutations (Fig. 2). These
changes will not be detected using techniques based on the
analysis of 16S RNA; however, they might be relevant since
different clones from the same bacterial species might differ
in more than 50% of their genome. On the other hand, the
enrichment of speciﬁc resistance genes or gene transfer ele-
ments may be a problem for the treatment of infectious dis-
eases.
Non-culture methods for tracking speciﬁc
genes: the concept of resistome
The analysis of resistance genes present in a wide number of
antibiotic producers demonstrated that natural ecosystems
contain a large number of resistance determinants [16].
Using functional metagenomics, the presence of resistance
genes in pristine regions such as Alaskan soils has been
described [17]. Nevertheless, the presence of a resistance
gene does not necessarily imply a risk for their dissemina-
tion. Usually the large majority of resistance genes present in
natural ecosystems do not resemble those found in clinical
settings [18]. This does not mean, however, that resistance
genes already disseminated among human pathogens are only
present in clinical ecosystems. On the contrary, PCR based
techniques have demonstrated their presence in several eco-
systems. These studies demonstrate that the release of anti-
biotic resistance elements causes an enrichment of some few
speciﬁc resistance genes in natural ecosystems [5]. The dis-
semination of these determinants and the impact that con-
tamination may have for their selection and maintenance
require the use of non-culture techniques targeting speciﬁc
genes. This applies for the elements involved in gene transfer
and recruitment (for instance the integrons). Although non-
culture-based methods have demonstrated that integron
integrases are present in all ecosystems, type I integrons,
which are widely distributed among human pathogens, are
not frequently present in natural (non-clinical) ecosystems,
indicating again that human activities might favour the enrich-
ment of some resistance determinants (Garmendia L,
Hernandez A, Sanchez MB, Martinez JL, unpublished data).
The recent analysis of the human gut resistome by using func-
tional metagenomics techniques reinforces this issue [19].
This study, made with healthy volunteers who did not
recently receive antibiotic treatment, demonstrated that
human microbiota contains a large number of resistance ele-
ments. Several of them are distinct from those acquired by
human pathogens through horizontal gene transfer (HGT)
and probably constitute the intrinsic resistome [20] of those
microorganisms. However, the microbiota harboured as well
genes coding for TEM-type, CblA, CfxA and CTX-M b-lacta-
mases, which are classical resistance determinants dissemi-
nated by HGT. The presence of these genes suggests that
they can be maintained in the gut microbiota in the absence
of selection and indicates that human microbiota can be a
reservoir for HGT-acquired resistance genes.
FIG. 2. Second-order selection of resistant clones or elements har-
bouring antibiotic resistance. The acquisition of resistance by a mem-
ber of a complex microbiota has consequences for the structure of
such microbiota that will depend on the presence of an antibiotic. In
the absence of antibiotic selective pressure, if the microbiota con-
tains intrinsically resistant microorganisms (black ovals) or one of
the members acquires a resistance determinant (star inside ovals),
the intrinsically resistant clone will be maintained at the same rate
and the acquired resistance gene will probably be lost if it confers a
ﬁtness cost (b). In these circumstances it is expected that the
homeostasis of the system is maintained (c). However, if the micro-
biota is submitted to antibiotic selective pressure (d), intrinsically
resistant clones will expand at the expense of the susceptible ones
that are killed by the antibiotics. In a similar way, those microorgan-
isms acquiring the resistance element will survive allowing the expan-
sion of the speciﬁc clones harbouring the resistance determinant.
Finally, the transfer of the resistance element will allow the survival
of other bacterial clones/species in the presence of the antibiotic. As
the consequence, the successful spread of this element will be
increased by a second-order selection process.
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In silico analysis of metagenomics and
antibiotics
The exponential increase of sequence databases from ge-
nomes and metagenomes allows the in silico analysis of resis-
tance elements. Conﬁrming data obtained at the bench-top
on the analysis of the distribution of type I integrons, the
study of available metagenomes indicates that they are usu-
ally absent in natural ecosystems. Indeed only one in more
than 500 available metagenomes harboured a type I integron
(Garmendia L, Hernandez A, Sanchez MB, Martinez JL,
unpublished data). This metagenome was analysed from the
sludge of a phosphorus removal processing plant, further
indicating that integrons are enriched in pathogenic bacteria,
maybe because they contain a gene coding for resistance to
sulfonamides, the ﬁrst group of widely used antibiotics. The
inspection of publicly available genomes and metagenomes
allows also the origin of resistance genes distributed among
human pathogens to be detected. As an example, it was
found that the quinolone resistance gene qnrA originated in
the water dwelling bacterial species Shewanella algae [21].
The search for available genomes and metagenomes demon-
strated that only bacteria with an aquatic habitat (mainly
from the sea) harbour in their chromosomes this family of
resistance elements, which might contribute to both intrin-
sic and acquired resistance [22,23]. This indicates that
the sea can be a reservoir of resistance genes that, as in
the case of qnrA, might be easily transferred to human
pathogens.
Concluding remarks
The use of non-culture techniques opens a new avenue for
study of the impact that antibiotics may have in different
ecosystems, for understanding the origin of resistance and
for analysing its dissemination with the aim of predicting the
emergence of resistance [24]. These topics can be addressed
using different non-culture-based approaches, from high cost
techniques such as massive sequencing to nearly cost-free
studies such as in silico analyses of currently available data-
bases. Despite the relevance of the problems to address and
the availability of this large rank of tools, several of them
amenable for their use in any laboratory, the number of
studies on metagenomics and antibiotics is still low. More
studies are thus required in the ﬁeld of metagenomics
and antibiotics to better understand antibiotic resistance and
to ﬁnd novel antimicrobials with the aid of functional
metagenomics.
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